|
市場調査レポート
商品コード
1166496
グルタチオンの世界市場：市場規模 - タイプ別、製品別、用途別、地域別展望、競合戦略、セグメント別予測（～2032年）Glutathione Market Size- By Type, By Product, By Application- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032 |
||||||
|
|
|||||||
| グルタチオンの世界市場：市場規模 - タイプ別、製品別、用途別、地域別展望、競合戦略、セグメント別予測（～2032年） |
|
出版日: 2022年11月30日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 250 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 目次
世界のグルタチオンの市場規模は、2032年までに10億3,000万米ドルに達し、CAGRで8.8%の成長が予測されています。
グルタチオンは、世界の医薬品および食品セクターにおける市場シェアが拡大すると予想されています。COVID-19の影響で、症状緩和のため市販薬を買いだめする人が多くなっています。免疫力強化のための商品需要も拡大しており、健康補助食品のニーズも高まっています。パンデミック時には、一般的な医薬品需要の増加により、グルタチオンの市場は増加すると予想されています。
当レポートでは、世界のグルタチオン市場について調査し、市場力学、市場変数と展望、タイプ・製品・用途・地域別の市場分析、企業プロファイル等に関する情報を提供しています。
目次
第1章 イントロダクション
- 調査範囲
- 市場セグメント分析
第2章 調査手法
- 調査データソース
- 市場規模の推定
- データの三角測量
第3章 エグゼクティブサマリー
第4章 市場力学
- 促進要因、抑制要因、機会、課題の分析
- 促進要因
- 抑制要因
- 機会
- 課題
- 世界のグルタチオン市場におけるCOVID-19の影響
第5章 市場変数と展望
- SWOT分析
- 強み
- 弱み
- 機会
- 脅威
- PESTEL分析
- 政治情勢
- 経済情勢
- 社会情勢
- 技術情勢
- 環境情勢
- 法的情勢
- ポーターのファイブフォース分析
- 供給企業の交渉力
- 買い手の交渉力
- 代替品の脅威
- 新規参入者の脅威
- 競合企業間の敵対関係
- ヒートマップ分析
第6章 世界のグルタチオン市場：タイプ別、2019年～2032年（100万米ドル）
- L-グルタチオン
- アセチルグルタチオン
第7章 世界のグルタチオン市場：製品別、2019年～2032年（100万米ドル）
- 酸化型グルタチオン
- 還元型グルタチオン
第8章 世界のグルタチオン市場：用途別、2019年～2032年（100万米ドル）
- 食品・飲料
- 免疫沈降（IP）
- パーソナルケア・化粧品
- 医薬品
- タンパク質精製
- 研究
- その他
第9章 世界のグルタチオン市場：地域別、2019年～2032年（100万米ドル）
- 北米
- 米国
- カナダ
- メキシコ
- 欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- その他の欧州
- アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋
- 南米
- ブラジル
- アルゼンチン
- その他の南米
- 中東・アフリカ
- サウジアラビア王国
- アラブ首長国連邦
- その他の中東・アフリカ
第10章 企業プロファイル
- Bio-Rad Laboratories Inc.
- 企業概要
- 財務見通し
- 製品概要
- 最近の開発
- Cytiva
- Jarrow Formulas Inc.
- Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
- Kohjin Life Sciences Co. Ltd.
- Kyowa Hakko Bio Co. Ltd.
- Merck KGaA
- Mitsubishi Corporation Life Sciences Ltd.
- Nissor Pharmaceuticals Ltd.
- Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- Shenzhen GSH Bio-Technology Co. Ltd.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Global Glutathione Market Overview:
According to SPER Market Research, the Global Glutathione Market is estimated to reach USD 1.03 billion by 2032 with a CAGR of 8.8%.
A tripeptide substance called glutathione is created from the amino acid glycine, cysteine, and glutamic acid. Important cellular components of the human body are susceptible to damage from reactive oxygen species, including free radicals, peroxides, lipid peroxides, and heavy metals. Glutathione aids in avoiding this damage. An essential antioxidant in the human body, glutathione helps fight free radicals, detoxify substances produced naturally by the body, as well as pharmaceuticals and environmental contaminants. Additionally, glutathione is used to treat impaired immune systems, infertility, and cancer's damaging side effects from radiation and chemotherapy. These advantages of the product ought to increase glutathione's market share in the global pharmaceutical and food sectors.
Impact of COVID-19 on the Global Glutathione Market
The COVID-19 epidemic has altered customers' purchasing behaviour. Panic purchases of food and sanitary supplies have resulted from measures like the countrywide lockdown. A growing number of patients are preferring self-medication over doctor visits in the wake of the COVID-19 issue. As a result, many people have stocked up on over-the-counter medications for symptom alleviation. The demand for goods that aid in strengthening immunity has also grown as a result of greater consumer knowledge of and interest in the significance of preventative health. The need for health supplements has increased as a result. During the pandemic, the market for glutathione is anticipated to rise because to the general increase in demand for medications.
Scope of the Report:
Report Metric Details
- Market size available for years: 2019-2032
- Base year considered: 2021
- Forecast period: 2022-2032
- Segments covered: By Type, By Product, By Application
- Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
- Companies Covered: Bio-Rad Laboratories Inc., Cytiva, Jarrow Formulas Inc., Kaiping Genuine Biochemical Pharmaceutical Co. Ltd., Kohjin Life Sciences Co. Ltd., Kyowa Hakko Bio Co. Ltd., Merck KGaA, Mitsubishi Corporation Life Sciences Ltd., Nissor Pharmaceuticals Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., Shenzhen GSH Bio-Technology Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc.
Global Glutathione Market Segmentation:
- By Type: Based on the Type, Global Glutathione Market is segmented as; L-Glutathione, Acetyl-Glutathione.
- By Product: Based on the Product, Global Glutathione Market is segmented as; Oxidized Glutathione, Reduced Glutathione.
- By Application: Based on the Application, Global Glutathione Market is segmented as; Food & Beverages, Immunoprecipitation, Personal Care & Cosmetics, Pharmaceuticals, Protein Purification, Research, Others.
- By Region: Over the projected period, Asia Pacific is expected to develop at the quickest CAGR of any major region, accounting for the greatest revenue share of all other regions. This share is attributable to the expanding government support for domestic manufacturing, which is predicted to increase output levels and lessen reliance on imports in the Asia Pacific area, providing profitable prospects for international manufacturers. Over the projected period, the market is also anticipated to be driven by the expanding pharmaceutical R&D industry. In terms of volume, North America is the largest market, and it is anticipated that it would expand at a significant CAGR over the forecast period. The development of vaccines to treat illnesses like the present Coronavirus pandemic and the increased need for biochemical research applications are two key reasons driving the regional industry. Demand for the product is anticipated to increase in North America due to the growing use of purified proteins and antibodies in medicinal applications.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
- 2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Glutathione Market
5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
- 5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
- 5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
- 5.4. Heat map analysis
6. Global Glutathione Market, By Type, 2019-2032 (USD Million)
- 6.1. L-Glutathione
- 6.2. Acetyl-Glutathione
7. Global Glutathione Market, By Product, 2019-2032 (USD Million)
- 7.1. Oxidized Glutathione
- 7.2. Reduced Glutathione
8. Global Glutathione Market, By Application, 2019-2032 (USD Million)
- 8.1. Food & Beverages
- 8.2. Immunoprecipitation (IP)
- 8.3. Personal Care & Cosmetics
- 8.4. Pharmaceuticals
- 8.5. Protein Purification
- 8.6. Research
- 8.7. Others
9. Global Glutathione Market, By Region, 2019-2032 (USD Million)
- 9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
- 9.2 Europe
- 9.2.1 Germany
- 9.2.2 United Kingdom
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Rest of Europe
- 9.3 Asia-Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
- 9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Rest of South America
- 9.5 Middle East & Africa
- 9.5.1 Kingdom of Saudi Arabia
- 9.5.2 United Arab Emirates
- 9.5.3 Rest of Middle East & Africa
10. Company Profiles
- 10.1 Bio-Rad Laboratories Inc.
- 10.1.1 Company details
- 10.1.2 Financial outlook
- 10.1.3 Product summary
- 10.1.4 Recent developments
- 10.2 Cytiva
- 10.2.1 Company details
- 10.2.2 Financial outlook
- 10.2.3 Product summary
- 10.2.4 Recent developments
- 10.3 Jarrow Formulas Inc.
- 10.3.1 Company details
- 10.3.2 Financial outlook
- 10.3.3 Product summary
- 10.3.4 Recent developments
- 10.4 Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
- 10.4.1 Company details
- 10.4.2 Financial outlook
- 10.4.3 Product summary
- 10.4.4 Recent developments
- 10.5 Kohjin Life Sciences Co. Ltd.
- 10.5.1 Company details
- 10.5.2 Financial outlook
- 10.5.3 Product summary
- 10.5.4 Recent developments
- 10.6 Kyowa Hakko Bio Co. Ltd.
- 10.6.1 Company details
- 10.6.2 Financial outlook
- 10.6.3 Product summary
- 10.6.4 Recent developments
- 10.7 Merck KGaA
- 10.7.1 Company details
- 10.7.2 Financial outlook
- 10.7.3 Product summary
- 10.7.4 Recent developments
- 10.8 Mitsubishi Corporation Life Sciences Ltd.
- 10.8.1 Company details
- 10.8.2 Financial outlook
- 10.8.3 Product summary
- 10.8.4 Recent developments
- 10.9 Nissor Pharmaceuticals Ltd.
- 10.9.1 Company details
- 10.9.2 Financial outlook
- 10.9.3 Product summary
- 10.9.4 Recent developments
- 10.10 Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- 10.10.1 Company details
- 10.10.2 Financial outlook
- 10.10.3 Product summary
- 10.10.4 Recent developments
- 10.11 Shenzhen GSH Bio-Technology Co. Ltd.
- 10.11.1 Company details
- 10.11.2 Financial outlook
- 10.11.3 Product summary
- 10.11.4 Recent developments
- 10.12 Takara Bio Inc.
- 10.12.1 Company details
- 10.12.2 Financial outlook
- 10.12.3 Product summary
- 10.12.4 Recent developments
- 10.13 Thermo Fisher Scientific Inc.
- 10.13.1 Company details
- 10.13.2 Financial outlook
- 10.13.3 Product summary
- 10.13.4 Recent developments
